Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,44723,1822,1.41 [1.24-1.60],1.8903276779630899e-07
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,43991,439,1.62 [1.26-2.08],0.0001936155243952
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,33784,1598,1.49 [1.29-1.72],3.229318237572241e-08
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,44542,117,2.18 [1.42-3.34],0.0003314841870301
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",48980,832,1.42 [1.18-1.71],0.0002092996936112
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,48721,573,1.59 [1.27-1.97],3.6138839902963895e-05
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",23336,674,1.55 [1.26-1.89],2.634578011466522e-05
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,50613,140,2.22 [1.54-3.20],1.724990463018203e-05
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,41766,2376,1.37 [1.22-1.54],1.4415637237224944e-07
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,47037,274,3.28 [2.53-4.24],1.8654564414254642e-19
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Peripheral artery disease,49315,227,1.84 [1.33-2.54],0.0002142412436563
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,47007,244,3.16 [2.43-4.13],1.8422242165306082e-17
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,47886,1123,2.53 [2.16-2.96],1.1509158404161198e-30
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,47849,1086,2.52 [2.14-2.95],1.235396318752563e-29
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,41420,2030,1.35 [1.19-1.54],2.8142553995665545e-06
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,41266,1876,1.37 [1.20-1.56],3.216724430319505e-06
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter V Mental and behavioural disorders,Any mental disorder,43722,1315,1.58 [1.37-1.83],8.159570749209132e-10
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",42866,459,1.96 [1.55-2.48],1.7153745740329875e-08
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",50903,342,1.92 [1.47-2.52],1.623588080928792e-06
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",51034,249,1.96 [1.43-2.68],2.358738396540477e-05
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter V Mental and behavioural disorders,Alcohol dependence,48161,141,2.21 [1.49-3.27],7.892347757109242e-05
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter V Mental and behavioural disorders,Smoking dependency,48053,120,2.08 [1.35-3.20],0.0008772650397426
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",43063,656,1.54 [1.26-1.88],2.8756871155224185e-05
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter V Mental and behavioural disorders,Depression or dysthymia,42550,498,1.50 [1.19-1.89],0.0005325008550337
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Neurological diseases,44196,2969,1.31 [1.18-1.45],1.744757170574335e-07
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,40126,266,2.26 [1.68-3.05],7.63959391424089e-08
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,51416,211,2.32 [1.74-3.09],7.719058182188601e-09
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,49011,976,1.44 [1.22-1.70],1.672503398408896e-05
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Epilepsy,48343,308,1.77 [1.35-2.33],3.919813255119543e-05
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,44519,323,1.64 [1.24-2.16],0.0005077729022352
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,49679,445,1.56 [1.23-1.99],0.0002657096499339
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,51031,108,2.70 [1.88-3.89],9.04533220504141e-08
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",46722,108,2.91 [2.04-4.15],4.136521761316874e-09
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,50429,137,0.33 [0.21-0.53],2.870169560459799e-06
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,"Hypertension, essential",38511,4557,1.33 [1.21-1.46],3.9860732179306075e-09
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Hypertension,38580,4626,1.34 [1.22-1.47],1.2313087736514623e-09
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,34117,163,1.98 [1.33-2.95],0.0007386209722605
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Secondary right heart disease,49998,176,0.40 [0.27-0.60],1.0806642007885073e-05
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,50000,178,0.40 [0.27-0.60],9.85029609418849e-06
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",34123,169,0.43 [0.28-0.65],0.0001005062306361
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Cardiomyopathy,42837,119,0.39 [0.24-0.64],0.0002381991691524
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Conduction disorders,42965,247,0.34 [0.24-0.49],2.648695339229589e-09
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,28478,237,0.52 [0.36-0.76],0.0005664024714832
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,29134,893,0.24 [0.20-0.29],1.412903828947245e-44
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Other arrhythmias,42855,137,0.33 [0.21-0.52],2.950106462039596e-06
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,42901,183,0.41 [0.27-0.61],1.3048266922404814e-05
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,"Heart failure, strict",49545,421,0.38 [0.29-0.49],4.350572352278245e-13
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,41230,4151,1.20 [1.10-1.31],5.88492679594609e-05
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Interstitial lung disease,48722,141,2.37 [1.66-3.39],2.2198602798527645e-06
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",51105,141,2.36 [1.65-3.38],2.553010201518192e-06
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,48708,127,2.50 [1.74-3.61],9.07461616806157e-07
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,35164,11703,1.20 [1.13-1.28],9.458346413486628e-09
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",43106,4363,1.27 [1.16-1.38],1.2020656590434814e-07
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Oesophagitis,39430,687,1.42 [1.15-1.74],0.0008560951050302
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),40382,1639,1.38 [1.21-1.58],2.673881361008984e-06
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,37019,578,1.59 [1.27-1.98],4.62575638750827e-05
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Constipation,48400,518,1.54 [1.22-1.93],0.0002611581588792
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Diseases of liver,50047,251,2.39 [1.81-3.15],5.999029168715633e-10
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,45326,3131,1.24 [1.12-1.37],3.0010113170620382e-05
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,37203,8010,1.22 [1.13-1.30],3.79462351261019e-08
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,40452,4647,1.19 [1.10-1.30],5.053608446206495e-05
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,46604,2429,1.21 [1.08-1.36],0.000787924458078
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,36103,298,1.95 [1.47-2.59],4.1406269869459554e-06
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,36737,932,1.46 [1.22-1.74],2.62455400589824e-05
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",50852,287,1.82 [1.38-2.39],2.223092588502461e-05
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,50875,260,1.84 [1.38-2.45],2.837757742837597e-05
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,50573,258,1.84 [1.37-2.47],4.407291974758939e-05
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,50425,110,2.09 [1.44-3.05],0.0001121349561477
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,46414,1862,1.24 [1.09-1.40],0.000881940607644
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,46388,512,1.57 [1.25-1.98],0.0001408466899229
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,46619,141,2.87 [2.01-4.09],5.960326233545117e-09
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,27884,885,0.59 [0.48-0.72],2.0099117851635058e-07
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,27889,1203,0.62 [0.52-0.75],2.260216992560638e-07
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,27152,153,0.44 [0.28-0.69],0.0002739625634227
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,27359,673,0.68 [0.54-0.86],0.0009340087951885
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,26445,132,0.44 [0.28-0.71],0.0006398502194795
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,27916,338,0.48 [0.36-0.65],1.703126957161446e-06
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,27836,258,0.46 [0.32-0.64],6.534194397733706e-06
